The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

The blood-brain barrier border protects the brain by regulating the flow of molecules, peptides, and cells, but it also keeps out many therapeutics. Now, researchers have harnessed the power of a ...

Dr. Gabor Balazsi, a Henry Laufer Professor of Physical and Quantitative Biology in the Laufer Center at Stony Brook ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

EditCo Bio has entered a strategic licensing agreement with Promega, securing access to the latter’s protein-tagging and ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Genome editing has progressed rapidly, showing promising outcomes for the treatment of genetic disorders, yet there remains ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

EditCo Bio, Inc. has announced a strategic licensing agreement with Promega Corporation, granting EditCo access to Promega HiBiT, HaloTag®, and NanoLuc® technologies. These advanced protein-tagging ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...